TOP NEWS: Imfinzi Fails To Meet Primary Endpoint In AstraZeneca Trial
LONDON (Alliance News) - Pharmaceticals form AstraZeneca PLC on Friday said its phase three Eagle trial of Imfinzi in advanced head and neck cancer patients failed to meet its primary study alone, Read More